A randomized, double-blind, placebo-controlled, multiple dose phase 2 study to determine the safety and efficacy of AMG 317 in subjects with moderate to severe asthma

Trial Profile

A randomized, double-blind, placebo-controlled, multiple dose phase 2 study to determine the safety and efficacy of AMG 317 in subjects with moderate to severe asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs AMG 317 (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jan 2010 Results published in the American Journal of Respiratory and Critical Care Medicine.
    • 14 Apr 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Actual patient number (294) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top